Date Filed | Type | Description |
05/26/2020 |
GN
| Beam Therapeutics to Present at Jefferies 2020 Virtual Healthcare Conference |
05/12/2020 |
GN
| Beam Therapeutics Reports Additional Data at ASGCT Annual Meeting and First Quarter 2020 Financial Results |
04/28/2020 |
GN
| Beam Therapeutics to Present First Data Highlighting Base Editing Program for Alpha-1 Antitrypsin Deficiency at 23rd ASGCT Annual Meeting |
04/28/2020 |
GN
| Beam Therapeutics to Present Updated Data Highlighting Base Editing Programs for Sickle Cell Disease at 23rd ASGCT Annual Meeting |
03/30/2020 |
GN
| Beam Therapeutics Reports Business Updates and Full Year 2019 Financial Results |
04/30/2014 |
8-K
| Quarterly results |
04/29/2014 |
10-K/A
| Annual Report for the period ended December 31, 2013 [amend] |
04/22/2014 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ... |
04/22/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
04/18/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/17/2014 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/15/2014 |
SC 13D/A
| Pershing Square reports a 5.5% stake in Beam Inc. |
04/09/2014 |
8-K
| Temporary Suspension of Trading Under Registrant's Employee Benefit Plans, Financial Statements and Exhibits |
03/27/2014 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
03/12/2014 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
03/05/2014 |
8-K
| Other Events, Financial Statements and Exhibits |
02/28/2014 |
8-K
| Other Events |
02/21/2014 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials: |
02/19/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
02/19/2014 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
02/18/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
02/18/2014 |
SC 13D/A
| Pershing Square reports a 7.1% stake in Beam Inc. |
02/14/2014 |
SC 13G/A
| FMR LLC reports a 3.8% stake in BEAM INC |
02/11/2014 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.5% stake in Beam Inc |
02/07/2014 |
SC 13G/A
| BlackRock Inc. reports a 4.8% stake in BEAM INC |
02/05/2014 |
8-K
| Quarterly results |
02/05/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
01/31/2014 |
SC 13D/A
| Pershing Square reports a 8.3% stake in Beam Inc. |
01/28/2014 |
SC 13G/A
| BlackRock Inc. reports a 5.1% stake in BEAM INC |
01/22/2014 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs:
|
"BEAM DECLARES REGULAR DIVIDEND Deerfield, Illinois, January 22, 2014 - Beam Inc. , a leading global premium spirits company, today declared a regular dividend of 22.5 cents per share on the company's common stock, payable in cash on March 3, 2014 to stockholders of record at the close of business on February 6, 2014. * * * About Beam Inc. As one of the world's leading premium spirits companies, Beam is Crafting the Spirits that Stir the World. Consumers from all corners of the globe call for the company's brands, including Jim Beam Bourbon, Maker's Mark Bourbon, Sauza Tequila, Pinnacle Vodka, Canadian Club Whisky, Courvoisier Cognac, Teacher's Scotch Whisky, Skinnygirl Cocktails, Cruzan Rum, Hornitos Tequila, Knob Creek Bourbon, Laphroaig Scotch Whisky, Kilbeggan Irish Whiskey, Larios Gin,..." |
|
01/22/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
01/13/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
01/13/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
01/13/2014 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
|